News
Manufacturer Lilly has announced plans to hike the amount it charges private providers in the UK to bring it into line with ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and stepping up competition with Eli Lilly's Mounjaro launched in the country eight ...
The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK ...
MOUNJARO prices in the UK could double as the manufacturer will next month hike the rate it charges pharmacies for the fat ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...
Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...
Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health, said: “The SURPASS-CVOT results show that Mounjaro preserved the cardioprotective benefit of Trulicity, a GLP-1 ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results